| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad047ed13b00191c8da105f0f18de972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c9b2146125baec28d38393cd3e5ba6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d215db0e86eec95bae03ea28458ec8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5865f067eac9a05fe9a67ce8f60be3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14827b869ceb2bf67b58cce893ef42a3 |
| publicationDate |
2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020331889-A1 |
| titleOfInvention |
Compounds for the degradation of stk4 and treatment of hematologic malignancies |
| abstract |
The application relates to a compound of Formula (I) which modulate the amount of STK4, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease or disorder associated with the modulation of STK4. |
| priorityDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |